No, Keppra (levetiracetam) should NOT be stopped suddenly
Levetiracetam must be withdrawn gradually to minimize the risk of withdrawal seizures, including status epilepticus (seizures that will not stop), which can be life-threatening 1.
Critical Safety Information
The FDA drug label explicitly warns against abrupt discontinuation 1:
- Stopping KEPPRA suddenly can cause serious problems
- Stopping a seizure medicine suddenly can cause seizures that will not stop (status epilepticus)
- Patients must not stop KEPPRA without first talking to a healthcare provider
The official prescribing information reinforces this: "Antiepileptic drugs, including KEPPRA, should be withdrawn gradually to minimize the potential of increased seizure frequency" 1.
Why Gradual Withdrawal Matters
Risk of Withdrawal Seizures
- Abrupt discontinuation can precipitate breakthrough seizures or status epilepticus
- This risk exists even in patients who were previously well-controlled
- Status epilepticus is a medical emergency with significant morbidity and mortality risk
Evidence from Clinical Practice
Research demonstrates that withdrawal-related adverse events are uncommon when levetiracetam is tapered appropriately. A crossover study found "no withdrawal-related adverse events were reported during the cross-titration period" when proper tapering protocols were followed 2.
Recommended Tapering Protocol
Based on clinical evidence 3, a structured withdrawal approach includes:
- Initial reduction: Decrease to 20 mg/kg every 12 hours for a 4-week seizure-free period
- Further reduction: Then decrease to 20 mg/kg every 24 hours for another 4-week seizure-free period
- Complete discontinuation: Only after successful completion of the above steps
Special Considerations
Patients at Higher Risk During Withdrawal
- Those with history of status epilepticus
- Patients with symptomatic generalized epilepsy 4
- Individuals with multiple seizure types
- Those on multiple antiepileptic drugs
Monitoring During Taper
- Close observation for seizure recurrence
- Watch for behavioral changes (irritability, mood alterations) 4, 5
- More gradual taper may be needed in high-risk patients
Clinical Pitfalls to Avoid
Do not assume levetiracetam is "safer" to stop abruptly simply because it has a favorable side effect profile during treatment. The withdrawal seizure risk applies to all antiepileptic drugs, including levetiracetam.
Do not discontinue without medical supervision, even if the patient has been seizure-free for an extended period. The decision to stop and the tapering schedule should be individualized based on seizure type, duration of seizure freedom, and underlying epilepsy syndrome.